A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
May 2020
Historique:
received: 13 10 2019
accepted: 20 01 2020
revised: 15 01 2020
pubmed: 3 2 2020
medline: 9 2 2021
entrez: 3 2 2020
Statut: ppublish

Résumé

Numerous cross-sectional studies report cognitive impairment in multiple sclerosis (MS), but longitudinal studies with sufficiently long-term follow-up are scarce. We aimed to investigate the cognitive 10-year course of a cohort of MS patients. 59 patients with clinically isolated syndrome (CIS) or relapsing-remitting (RR) MS were evaluated with Rao's Brief Repeatable Battery of Neuropsychological Tests at baseline and follow-up (at least 10 years later). They constituted 47.2% of 124 consecutive CIS and RRMS patients originally evaluated at baseline. Patients assessed at follow-up were well matched for baseline clinical characteristics with dropouts. The proportion of MS patients with overall cognitive impairment was increased by 10% within the 10-year period. When grouped on the basis of impairment in specific cognitive domains at baseline, patients originally impaired showed improvement at follow-up, while the opposite trend was observed for patients non-impaired at first assessment. A detailed case-by-case investigation revealed mixed evolution patterns, several patients fail in fewer domains at follow-up compared to baseline or failing at different domains at follow-up compared to baseline. This study suggests a more fluid picture for the evolution of cognitive function in a subgroup of MS patients and contradicts the concept of an inevitable, progressively evolving "dementia".

Sections du résumé

BACKGROUND BACKGROUND
Numerous cross-sectional studies report cognitive impairment in multiple sclerosis (MS), but longitudinal studies with sufficiently long-term follow-up are scarce.
OBJECTIVE OBJECTIVE
We aimed to investigate the cognitive 10-year course of a cohort of MS patients.
METHODS METHODS
59 patients with clinically isolated syndrome (CIS) or relapsing-remitting (RR) MS were evaluated with Rao's Brief Repeatable Battery of Neuropsychological Tests at baseline and follow-up (at least 10 years later). They constituted 47.2% of 124 consecutive CIS and RRMS patients originally evaluated at baseline. Patients assessed at follow-up were well matched for baseline clinical characteristics with dropouts.
RESULTS RESULTS
The proportion of MS patients with overall cognitive impairment was increased by 10% within the 10-year period. When grouped on the basis of impairment in specific cognitive domains at baseline, patients originally impaired showed improvement at follow-up, while the opposite trend was observed for patients non-impaired at first assessment. A detailed case-by-case investigation revealed mixed evolution patterns, several patients fail in fewer domains at follow-up compared to baseline or failing at different domains at follow-up compared to baseline.
CONCLUSIONS CONCLUSIONS
This study suggests a more fluid picture for the evolution of cognitive function in a subgroup of MS patients and contradicts the concept of an inevitable, progressively evolving "dementia".

Identifiants

pubmed: 32008073
doi: 10.1007/s00415-020-09720-8
pii: 10.1007/s00415-020-09720-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1464-1475

Subventions

Organisme : State Scholarships Foundation
ID : MIS-5000432

Références

Bergendal G, Fredrikson S, Almkvist O (2007) Selective decline in information processing in subgroups of multiple sclerosis: an 8 year old longitudinal study. Eur Neurol 57:193–202
pubmed: 17272938 doi: 10.1159/000099158
DeLuca J, Chelune GJ, Tulsky DS et al (2004) Is speed of processing or working memory the primary information processing deficit in multiple sclerosis? J Clin Exp Neuropsychol 26:550–562
pubmed: 15512942 doi: 10.1080/13803390490496641
Janculjak D, Mubrin A, Brinar V et al (2002) Changes of attention and memory in a group of patients with multiple sclerosis. Clin Neurol Neurosurg 104:221–227
pubmed: 12127658 doi: 10.1016/S0303-8467(02)00042-2
Brassington JC, Marsh NV (1998) Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 8:43–77
pubmed: 9658410 doi: 10.1023/A:1025621700003
DeLuca J, Barbieri-Berger S, Johnson SK (1994) The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 16:183–189
pubmed: 8021305 doi: 10.1080/01688639408402629
Rao SM, Grafman J, DiGuilio D et al (1993) Memory dysfunction in multiple sclerosis: its relation to working memory, semantic encoding and implicit learning. Neuropsychology 7:364–374
doi: 10.1037/0894-4105.7.3.364
Rao SM, Leo GJ, Bernardin L et al (1991) Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 41(5):685–691
pubmed: 2027484 doi: 10.1212/WNL.41.5.685
Filley CM (2012) White matter dementia. Ther Adv Neurol Disord 5(5):267–277
pubmed: 22973423 pmcid: 3437529 doi: 10.1177/1756285612454323
Benedict RH, Bobholz JH (2007) Multiple sclerosis. Semin Neurol 27(1):78–85
pubmed: 17226744 doi: 10.1055/s-2006-956758
Amato MP, Ponziani G, Siracusa G et al (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch Neurol 58(10):1602–1606
pubmed: 11594918 doi: 10.1001/archneur.58.10.1602
Strober LB, Rao SM, Lee JC, Fischer E et al (2014) Cognitive impairment in multiple sclerosis: an 18year follow-up study. Mult Scler Relat Disord 3:473–481
pubmed: 25877059 doi: 10.1016/j.msard.2014.03.004
Schwid SR, Goodman AD, Weinstein A et al (2007) Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci 255(1):57–63
pubmed: 17331542 doi: 10.1016/j.jns.2007.01.070
Potagas C, Giogkaraki E, Koutsis G et al (2007) Cognitive impairment in different MS subtypes and clinically isolated syndromes. J Neurol Sci 267(1):100–106
pubmed: 17997417
Kurtzke JF (1998) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452
doi: 10.1212/WNL.33.11.1444
Lechner-Scott J, Kappos L, Hofman M et al (2003) Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 9(2):154–159
pubmed: 12708811 doi: 10.1191/1352458503ms884oa
Mantzavinou P (2016) Rao’s brief repeatable battery in multiple sclerosis. Normative data in the Greek population (oral presentation). In: Cognitive impairment in MS: from pathology to phenomenology, Poros, Greece, 17–20 June, 2016 (in Greek)
Achiron A, Chapman J, Magalashvili D et al (2013) Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS ONE 8(8):e71058
pubmed: 23936485 pmcid: 3731335 doi: 10.1371/journal.pone.0071058
Jønsson A, Andresen J, Storr L et al (2006) Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J Neurol Sci 245(1–2):77–85
pubmed: 16647089 doi: 10.1016/j.jns.2005.09.016
Mariani C, Farina E, Cappa SF et al (1991) Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging. J Neurol 238(7):395–400
pubmed: 1960544 doi: 10.1007/BF00319859
Patti F, Failla G, Ciancio MR et al (1998) Neuropsychological, neuroradiological and clinical findings in multiple sclerosis. A 3 year follow-up study. Eur J Neurol 5(3):283–286
pubmed: 10210843 doi: 10.1046/j.1468-1331.1998.530283.x
Uher T, Blahova-Dusankova J, Horakova D et al (2014) Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. J Neurol 261(9):1735–1744
pubmed: 24952618 doi: 10.1007/s00415-014-7413-9
Piras MR, Magnano I, Canu ED et al (2003) Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 74(7):878–885
pubmed: 12810771 pmcid: 1738564 doi: 10.1136/jnnp.74.7.878
Glanz BI, Healy BC, Hviid LE et al (2012) Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry 83(1):38–43
pubmed: 21746743 doi: 10.1136/jnnp.2010.237834
Audoin B, Ibarrola D, Ranjeva JP et al (2003) Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of multiple sclerosis. Hum Brain Mapp 20(2):51–58
pubmed: 14505331 doi: 10.1002/hbm.10128 pmcid: 6872003
Mainero C, Caramia F, Pozzilli C et al (2004) fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis. Neuroimage 21(3):858–867
pubmed: 15006652 doi: 10.1016/j.neuroimage.2003.10.004
Rocca MA, Valsasina P, Ceccarelli A et al (2009) Structural and functional MRI correlates of Stroop control in benign MS. Hum Brain Mapp 30(1):276–290
pubmed: 18041737 doi: 10.1002/hbm.20504
Filippi M, Rocca MA (2013) Present and future of fMRI in multiple sclerosis. Expert Rev Neurother 13(sup2):27–31
pubmed: 24289839 doi: 10.1586/14737175.2013.865871
Leavitt VM, Wylie G, Genova HM et al (2012) Altered effective connectivity during performance of an information processing speed task in multiple sclerosis. Mult Scler 18(4):409–417
pubmed: 21965419 doi: 10.1177/1352458511423651
Pardini M, Uccelli A, Grafman J et al (2014) Isolated cognitive relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry 85(9):1035–1037
pubmed: 24686566 doi: 10.1136/jnnp-2013-307275
Ribbons K, Lea R, Schofield PW et al (2016) Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort. J Neuropsychiatry Clin Neurosci 29(2):128–134
pubmed: 27899051 doi: 10.1176/appi.neuropsych.16050085
Amato MP, Ponziani G, Pracucci G et al (1995) Cognitive impairment in early-onset multiple sclerosis: pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol 52(2):168–172
pubmed: 7848126 doi: 10.1001/archneur.1995.00540260072019
Bsteh G, Ehling R, Lutterotti A et al (2016) Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study. PLoS ONE 11(7):e0158978
pubmed: 27391947 pmcid: 4938610 doi: 10.1371/journal.pone.0158978
Drew M, Tippett LJ, Starkey NJ et al (2008) Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol 23(1):1–9
pubmed: 17981008 doi: 10.1016/j.acn.2007.09.005

Auteurs

Marina Katsari (M)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Dimitrios S Kasselimis (DS)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece. dkasselimis@gmail.com.
Department of Psychiatry, School of Medicine, University of Crete, Heraklion, Greece. dkasselimis@gmail.com.

Erasmia Giogkaraki (E)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Marianthi Breza (M)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Maria-Eleftheria Evangelopoulos (ME)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Maria Anagnostouli (M)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Elisabeth Andreadou (E)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Costas Kilidireas (C)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Alia Hotary (A)

School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Ioannis Zalonis (I)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Georgios Koutsis (G)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Constantin Potagas (C)

1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, 74 Vas. Sofias Av., 11528, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH